| Company Name: | Danaher Corporation | | Ticker Symbol: | DHR | | | WWW Address: | www.danaher.com | | CEO: | H. Lawrence Culp, Jr. | | No. of Employees: | 50,300 | | Common Issue Type: | CS | | Business Description: | The Company designs, manufactures and markets professional, medical, industrial and consumer products.
|
| | | Industry Information: | CONGLOMERATES - Conglomerates [more like this] |
| | Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 71.83 |  0.0 | - | - | 0 | 72.11 | 71.45 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 23,071.8 | 321.2 | 0.82 | 3.95 | 0.12 | 20.1 | 0.2 | 73.81 - 47.20 |
| | KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 71.98 | $ | | PE Ratio - LTM | 20.1 | |
| Market Capitalisation | 23,122.5 | mil |
| Latest Shares Outstanding | 321.2 | mil |
| Earnings pS (EPS) | 3.95 | $ |
| Dividend pS (DPS) | 0.12 | ¢ |
| Dividend Yield | 0.2 | % |
| Dividend Payout Ratio | 3 | % |
| Revenue per Employee | 252,435 | $ |
| Effective Tax Rate | 24.7 | % |
| Float | 285.0 | mil |
| Float as % of Shares Outstanding | 88.7 | % |
| Foreign Sales | 6,051 | mil |
| Domestic Sales | 6,647 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 28.10 | % |
| Research & Devlopment (R&D) as % of Revenue | 5.80 | % |
| Gross Profit Margin | 50.1 | % |
| EBITDA Margin | 16.2 | % |
| Pre-Tax Profit Margin | 13.1 | % |
| Assets Turnover | 0.6 | % |
| Return on Assets (ROA) | 6.2 | % |
| Return on Equity (ROE) | 10.6 | % |
| Return on Capital Invested (ROCI) | 8.4 | % |
| Current Ratio | 1.9 | |
| Leverage Ratio (Assets/Equity) | 1.7 | |
| Interest Cover | 14.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.26 | |
| LT Debt/Total Capital | 21.0 | % |
| Working Capital pS | 7.85 | $ |
| Cash pS | 5.09 | $ |
| Book-Value pS | 34.90 | $ |
| Tangible Book-Value pS | -3.04 | $ |
| Cash Flow pS | 4.75 | $ |
| Free Cash Flow pS | 3.49 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 2.06 | |
| Price/Tangible Book Ratio | -23.67 | |
| Price/Cash Flow | 15.1 | |
| Price/Free Cash Flow | 20.6 | |
| P/E as % of Industry Group | 119.0 | % |
| P/E as % of Sector Segment | 119.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Dividend Declared Date | 09/20/2009 |
| Dividend Ex-Date | 09/22/2009 |
| Dividend Record Date | 09/24/2009 |
| Dividend Pay Date | 10/29/2009 |
| Dividend Amount | 30 |
| Type of Payment | Cash Payment |
| Dividend Rate | 0.12 |
| Current Dividend Yield | 0.2 |
| 5-Y Average Dividend Yield | 0.1 |
| Payout Ratio | 3.0 |
| 5-Y Average Payout Ratio | 2.0 |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | | | | | PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.4 | 99 | 14,992 | 41,354 |
| 4 Weeks | 73.81 | 67.59 | 68.23 | 5.5 | 98 | 17,576 | 316,367 |
| 13 Weeks | 73.81 | 60.14 | 61.59 | 16.9 | 108 | 22,875 | 1,418,233 |
| 26 Weeks | 73.81 | 57.04 | 60.35 | 19.3 | 99 | 21,218 | 2,673,437 |
| 52 Weeks | 73.81 | 47.20 | 55.64 | 29.4 | 104 | 24,309 | 6,077,209 |
| YTD | 73.81 | 47.73 | - | 27.2 | 103 | 23,843 | 5,436,182 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 71.94 | 72.33 | 69.39 | 64.29 | 61.50 | 0.82 | 0.78 |
| | | | GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 12.68 | 88.5 | 7.30 |
| Income | 11.51 | 73.1 | 2.15 |
| Dividend | 18.48 | 96.4 | 14.54 |
| Capital Spending | 17.46 | NA | -11.10 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 10.98 | NA | 2.51 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | -15.4 | -14.3 | 15.2 |
| Earnings % | -12.6 | -5.5 | -3.8 |
| EPS % | -12.2 | -5.4 | -5.7 |
| EPS $ | -0.37 | -0.06 | -0.24 |
| | | | SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 8.24 |
| Current Ratio | 1.5 |
| Quick Ratio (Acid Test) | 0.8 |
| Liquidity Ratio (Cash) | 0.14 |
| Receivables Turnover | 6.5 |
| Average Collection Period | 55 |
| Working Capital/Equity | 14.7 |
| Working Capital pS | 4.52 |
| Cash-Flow pS | 5.20 |
| Free Cash-Flow pS | 3.78 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 3.07 |
| Financial Leverage Ratio (Assets/Equity) | 1.8 |
| Debt Ratio | 43.9 |
| Total Debt/Equity (Gearing Ratio) | 0.27 |
| LT Debt/Equity | 0.26 |
| LT Debt/Capital Invested | 39.9 |
| LT Debt/Total Liabilities | 33.2 |
| Interest Cover | 14.4 |
| Interest/Capital Invested | 0.88 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 8.77 |
| Tobin's Q Ratio | 1.32 |
| Current P/E Ratio - LTM | 20.10 |
| Enterprise Value (EV)/EBITDA | 13.77 |
| Enterprise Value (EV)/Free Cash Flow | 29.43 |
| Dividend Yield | 0.2 |
| Price/Tangible Book Ratio - LTM | -23.67 |
| Price/Book Ratio - LTM | 2.06 |
| Price/Cash Flow Ratio | 15.1 |
| Price/Free Cash Flow Ratio - LTM | 20.6 |
| Price/Sales Ratio | 2.06 |
| P/E Ratio (1 month ago) - LTM | 19.6 |
| P/E Ratio (26 weeks ago) - LTM | 15.7 |
| P/E Ratio (52 weeks ago) - LTM | 13.9 |
| 5-Y High P/E Ratio | 25.6 |
| 5-Y Low P/E Ratio | 11.9 |
| 5-Y Average P/E Ratio | 20.3 |
| Current P/E Ratio as % of 5-Y Average P/E | 99 |
| P/E as % of Industry Group | 119.0 |
| P/E as % of Sector Segment | 119.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 20.1 |
| PER SHARE FIGURES |
| LT Debt pS | 8.01 |
| Current Liabilities pS | 8.61 |
| Tangible Book Value pS - LTM | -3.04 |
| Book Value pS - LTM | 34.90 |
| Capital Invested pS | 38.48 |
| Cash pS - LTM | 5.09 |
| Cash Flow pS - LTM | 4.75 |
| Free Cash Flow pS - LTM | 3.49 |
| Earnings pS (EPS) | 3.95 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 9.48 |
| Free Cash Flow Margin 5YEAR AVG | -6.18 |
| Net Profit Margin | 10.4 |
| Net Profit Margin - 5YEAR AVRG. | 11.3 |
| Equity Productivity | 1.29 |
| Return on Equity (ROE) | 13.4 |
| Return on Equity (ROE) - 5YEAR AVRG. | 15.5 |
| Capital Invested Productivity | 1.03 |
| Return on Capital Invested (ROCI) | 10.7 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 12.0 |
| Assets Productivity | 0.70 |
| Return on Assets (ROA) | 7.5 |
| Return on Assets (ROA) - 5YEAR AVRG. | 8.3 |
| Gross Profit Margin | 50.1 |
| Gross Profit Margin - 5YEAR AVRG. | 47.1 |
| EBITDA Margin - LTM | 16.2 |
| EBIT Margin - LTM | 14.1 |
| Pre-Tax Profit Margin | 13.8 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 14.8 |
| Effective Tax Rate | 24.7 |
| Effective Tax Rate - 5YEAR AVRG. | 25.9 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 120 |
| Revenue per Employee | 252,435 |
| Net Income per Employee | 26,195 |
| Average Collection Period | 54 |
| Receivables Turnover | 6.5 |
| Day's Inventory Turnover Ratio | 66 |
| Inventory Turnover | 5.5 |
| Inventory/Sales | 9.0 |
| Accounts Payble/Sales | 8.73 |
| Assets/Revenue | 1.43 |
| Net Working Capital Turnover | 8.81 |
| Fixed Assets Turnover | 0.95 |
| Total Assets Turnover | 0.7 |
| Revenue per $ Cash | 32.32 |
| Revenue per $ Plant | 11.45 |
| Revenue per $ Common Equity | 1.29 |
| Revenue per $ Capital Invested | 1.03 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 26.3 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 26.5 |
| Research & Devlopment (R&D) as % of Revenue | 5.7 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 5.7 |
|
|  
| | |  |  | |
| |